Moreover Zhao et al. confirmed the essential oncogenic role of TET1 in the development of myeloid malignancies [15], Wang et al., found high TET1 expressers harbored poor overall survival in CN-AML patients [17]. The gene discussed is TET1; the disease is myeloid neoplasm.